US-based Illumina has obtained premarket clearance from the US Food and Drug Administration (FDA) for the MiSeqDx system, a high-throughput DNA sequencing analyzer. The company has also obtained premarket clearance from the FDA for the ...
Tags: Illumina, MiSeqDx System
Mobidiag, Genewave and Amplidiag have signed a definitive agreement to combine the three companies to set up a new company, which will offer integrated, high-multiplex diagnostic tests for infectious diseases. Headquartered in Helsinki, ...
Tags: Mobidiag, Genewave, Infectious Diseases
Affymetrix and Korean genomics-based biotechnology company DNA Link have signed Powered by Affymetrix (PbA) Program agreement for developing new molecular diagnostic tests for personalized healthcare. Under the agreement, DNA Link gained ...
Tags: DNA Link, forensic test development, molecular diagnostic tests
The US Court of Appeals for the Federal Circuit has upheld that the Myriad Genetics composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under Section 101 of the US Patent Act. ...
Tags: BRCA 1 genes, BRCA 2 genes, isolated DNA, Myriad Genetics
Affymetrix and PathGEN Dx have entered into an agreement for the development of an in-vitro diagnostic kit for pathogen detection. Under the agreement, PathGEN Dx will use its PathGEN PathChip for the development of the kit, designed to ...
Tags: in-vitro diagnostic kit, kit for pathogen detection, samples